Clinical Trial Update: An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating safety and efficacy of QL-007 tablets in combination with entecavir or tenofovir for chronic hepatitis B patients previously treated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• QL-007 (QL-007)
• Tenofovir (Tenofovir)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Chronic Hepatitis b | Phase 2 | Status: UNKNOWN